Culturally Centering Medications for Opioid Use Disorder With American Indian and Alaska Native Communities
CTN-0096
1 other identifier
interventional
48
1 country
3
Brief Summary
This is a formative research study to test a culturally-centered, program-level implementation intervention to increase the use of medications for opioid use disorder in four healthcare and addiction specialty treatment sites serving American Indian and Alaska Native communities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2021
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2021
CompletedFirst Posted
Study publicly available on registry
July 12, 2021
CompletedStudy Start
First participant enrolled
December 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 16, 2025
CompletedJune 29, 2025
June 1, 2025
3 years
July 6, 2021
June 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
# consumers with OUD initiated onto MOUD
number of consumers with OUD initiated onto MOUD in the 6 months after intervention delivery compared to pre-intervention
6 months
Secondary Outcomes (3)
# consumers with OUD offered MOUD
6 months
# consumers screened for OUD of the overall # of new consumers
6 months
# consumers with OUD retained in care for at least three months
6 months
Study Arms (1)
Culturally Centered MOUD Implementation
EXPERIMENTALCulturally centered program-level implementation intervention to increase the use of medications for opioid use disorder in healthcare and treatment settings serving AI/AN communities
Interventions
Support clinical sites to culturally center the delivery of medications for opioid use disorder through evidence-based implementation strategies tailored to local needs
Eligibility Criteria
You may qualify if:
- Willing and able to provide informed consent
- English comprehension and proficiency
- Receiving services at a participating study site
- Meet criteria for a current opioid use disorder
- Self-identify as American Indian or Alaska Native
- Willing to have program data linked to assessment data
- years or older
You may not qualify if:
- participation in research assessments contraindicated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- New York State Psychiatric Institutelead
- University of New Mexicocollaborator
Study Sites (3)
Southcentral Foundation
Anchorage, Alaska, 99508, United States
Native American Community Clinic
Minneapolis, Minnesota, 55404, United States
Missouri Breaks
Eagle Butte, South Dakota, 57625, United States
Related Publications (2)
Hirchak KA, Nadeau M, Vasquez A, Hernandez-Vallant A, Smith K, Pham C, Oliver KA, Baukol P, Lizzy K, Shaffer R, Herron J, Campbell ANC, Venner KL; CTN-0096 Collaborative Board. Centering culture in the treatment of opioid use disorder with American Indian and Alaska Native Communities: Contributions from a National Collaborative Board. Am J Community Psychol. 2023 Mar;71(1-2):174-183. doi: 10.1002/ajcp.12620. Epub 2022 Aug 23.
PMID: 35997562BACKGROUNDPaschen-Wolff MM, Campbell ANC, Vasquez A, Kessler J, Jansen K, Arnatt CP, Rosa C, Hebden HM, Radin S, Stately A, Shaw J, Kennedy F, Matthews AG, Venner KL. Conducting an implementation intervention study with American Indian and Alaska Native communities: Methodological considerations. Contemp Clin Trials. 2025 Aug;155:107992. doi: 10.1016/j.cct.2025.107992. Epub 2025 Jun 20.
PMID: 40544955DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Scientist
Study Record Dates
First Submitted
July 6, 2021
First Posted
July 12, 2021
Study Start
December 20, 2021
Primary Completion
December 13, 2024
Study Completion
January 16, 2025
Last Updated
June 29, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share
Data from this study is owned by participating Tribal clinical sites; any use of IPD requires Tribal (or equivalent organizational) approval.